Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Combination of Daratumumab and BD Regimen and Dapagliflozin in the Treatment of M-protein Related Cardiac Disease

  • Read more about Combination of Daratumumab and BD Regimen and Dapagliflozin in the Treatment of M-protein Related Cardiac Disease

A Two Year Longitudinal Clinical Study of Neurocognitive and Psychiatric Symptoms in Post COVID-19 Patients

  • Read more about A Two Year Longitudinal Clinical Study of Neurocognitive and Psychiatric Symptoms in Post COVID-19 Patients

Mushroom-based Product for COVID-19

  • Read more about Mushroom-based Product for COVID-19

Prevalence of Persistent COVID-19 in Punta Arenas, Magallanes and Chilean Antarctic Region

  • Read more about Prevalence of Persistent COVID-19 in Punta Arenas, Magallanes and Chilean Antarctic Region

Indapta Therapeutics, Inc.

By jpalfreyman on Tue, 03/05/2024 - 14:34
  • Read more about Indapta Therapeutics, Inc.

SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19

  • Read more about SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19

Predictors of Post-COVID-19 Clinical and Cognitive Consequences

  • Read more about Predictors of Post-COVID-19 Clinical and Cognitive Consequences

A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine

  • Read more about A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine

The Phase Ⅱ/Ⅲ Trial of LYB001

  • Read more about The Phase Ⅱ/Ⅲ Trial of LYB001

Multiple-Center Retrospective Study of Severe and Critical COVID-19 in Shanghai

  • Read more about Multiple-Center Retrospective Study of Severe and Critical COVID-19 in Shanghai

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 75
  • Page 76
  • Page 77
  • Page 78
  • Current page 79
  • Page 80
  • Page 81
  • Page 82
  • Page 83
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA